WO2023221994A1 - Composition de protéine de lait, son procédé de préparation et son utilisation - Google Patents
Composition de protéine de lait, son procédé de préparation et son utilisation Download PDFInfo
- Publication number
- WO2023221994A1 WO2023221994A1 PCT/CN2023/094598 CN2023094598W WO2023221994A1 WO 2023221994 A1 WO2023221994 A1 WO 2023221994A1 CN 2023094598 W CN2023094598 W CN 2023094598W WO 2023221994 A1 WO2023221994 A1 WO 2023221994A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactoglobulin
- milk protein
- weight
- protein composition
- casein
- Prior art date
Links
- 102000014171 Milk Proteins Human genes 0.000 title claims abstract description 160
- 108010011756 Milk Proteins Proteins 0.000 title claims abstract description 160
- 235000021239 milk protein Nutrition 0.000 title claims abstract description 153
- 239000000203 mixture Substances 0.000 title claims abstract description 128
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 102000008192 Lactoglobulins Human genes 0.000 claims abstract description 172
- 108010060630 Lactoglobulins Proteins 0.000 claims abstract description 171
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 101
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 74
- 102000004169 proteins and genes Human genes 0.000 claims description 67
- 235000018102 proteins Nutrition 0.000 claims description 63
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 42
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims description 28
- 235000018368 Saccharomyces fragilis Nutrition 0.000 claims description 28
- 229940031154 kluyveromyces marxianus Drugs 0.000 claims description 28
- 238000003259 recombinant expression Methods 0.000 claims description 28
- 230000015556 catabolic process Effects 0.000 claims description 22
- 238000006731 degradation reaction Methods 0.000 claims description 21
- 241001138401 Kluyveromyces lactis Species 0.000 claims description 18
- 238000000746 purification Methods 0.000 claims description 13
- 241001494479 Pecora Species 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 11
- 101001008231 Bos taurus Beta-lactoglobulin Proteins 0.000 claims description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 230000000593 degrading effect Effects 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 75
- 238000000855 fermentation Methods 0.000 description 62
- 230000004151 fermentation Effects 0.000 description 62
- 102000011632 Caseins Human genes 0.000 description 53
- 108010076119 Caseins Proteins 0.000 description 53
- 244000253911 Saccharomyces fragilis Species 0.000 description 52
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- 239000000523 sample Substances 0.000 description 36
- 238000001728 nano-filtration Methods 0.000 description 33
- 239000007788 liquid Substances 0.000 description 30
- 239000006228 supernatant Substances 0.000 description 29
- 108010063045 Lactoferrin Proteins 0.000 description 25
- 102000010445 Lactoferrin Human genes 0.000 description 25
- 150000001413 amino acids Chemical class 0.000 description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 24
- 235000021242 lactoferrin Nutrition 0.000 description 24
- 229940078795 lactoferrin Drugs 0.000 description 24
- 102000004407 Lactalbumin Human genes 0.000 description 23
- 108090000942 Lactalbumin Proteins 0.000 description 22
- 239000012528 membrane Substances 0.000 description 21
- 235000021241 α-lactalbumin Nutrition 0.000 description 21
- 235000021246 κ-casein Nutrition 0.000 description 21
- 108050000244 Alpha-s1 casein Proteins 0.000 description 20
- 102000009366 Alpha-s1 casein Human genes 0.000 description 20
- 102000004264 Osteopontin Human genes 0.000 description 19
- 108010081689 Osteopontin Proteins 0.000 description 19
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 19
- 235000021247 β-casein Nutrition 0.000 description 19
- 108050001786 Alpha-s2 casein Proteins 0.000 description 18
- 241000283153 Cetacea Species 0.000 description 17
- 241000406668 Loxodonta cyclotis Species 0.000 description 17
- 241000282320 Panthera leo Species 0.000 description 17
- 241000282376 Panthera tigris Species 0.000 description 17
- 241000282458 Ursus sp. Species 0.000 description 17
- 238000000108 ultra-filtration Methods 0.000 description 17
- 241000282836 Camelus dromedarius Species 0.000 description 16
- 241000283707 Capra Species 0.000 description 16
- 239000005018 casein Substances 0.000 description 15
- 241000283073 Equus caballus Species 0.000 description 14
- 238000001514 detection method Methods 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 13
- 235000021240 caseins Nutrition 0.000 description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 229930182830 galactose Natural products 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 10
- 239000008267 milk Substances 0.000 description 10
- 210000004080 milk Anatomy 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 8
- 241000282461 Canis lupus Species 0.000 description 8
- 241000700199 Cavia porcellus Species 0.000 description 8
- 241000282693 Cercopithecidae Species 0.000 description 8
- 241000289427 Didelphidae Species 0.000 description 8
- 241001144268 Echidna Species 0.000 description 8
- 241000283074 Equus asinus Species 0.000 description 8
- 241000282326 Felis catus Species 0.000 description 8
- 241000282575 Gorilla Species 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 241000282620 Hylobates sp. Species 0.000 description 8
- 241000288904 Lemur Species 0.000 description 8
- 241000282553 Macaca Species 0.000 description 8
- 241000289619 Macropodidae Species 0.000 description 8
- 241001503485 Mammuthus Species 0.000 description 8
- 241000282537 Mandrillus sphinx Species 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 241001482592 Oreamnos americanus Species 0.000 description 8
- 208000025174 PANDAS Diseases 0.000 description 8
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 8
- 241000282577 Pan troglodytes Species 0.000 description 8
- 240000004718 Panda Species 0.000 description 8
- 235000016496 Panda oleosa Nutrition 0.000 description 8
- 241001504519 Papio ursinus Species 0.000 description 8
- 241000009328 Perro Species 0.000 description 8
- 241000282405 Pongo abelii Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 241000555745 Sciuridae Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 241000282898 Sus scrofa Species 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 241000282485 Vulpes vulpes Species 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- 238000005374 membrane filtration Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 229920001184 polypeptide Polymers 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 241000235058 Komagataella pastoris Species 0.000 description 7
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 7
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 7
- 102000007544 Whey Proteins Human genes 0.000 description 7
- 108010046377 Whey Proteins Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000019621 digestibility Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000002538 fungal effect Effects 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- 239000012466 permeate Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 241000235649 Kluyveromyces Species 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 5
- 241000235648 Pichia Species 0.000 description 5
- 239000013566 allergen Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 235000013350 formula milk Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 238000011218 seed culture Methods 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 4
- 244000057717 Streptococcus lactis Species 0.000 description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000005571 anion exchange chromatography Methods 0.000 description 4
- 235000020247 cow milk Nutrition 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 208000012788 shakes Diseases 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- AAXWBCKQYLBQKY-IRXDYDNUSA-N (2s)-2-[[(2s)-2-[(2-benzamidoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)C=1C=CC=CC=1)C1=CN=CN1 AAXWBCKQYLBQKY-IRXDYDNUSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 241000223259 Trichoderma Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004042 decolorization Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 108010016268 hippuryl-histidyl-leucine Proteins 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 2
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 2
- 241000187844 Actinoplanes Species 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 241000193749 Bacillus coagulans Species 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 101000946377 Bos taurus Alpha-lactalbumin Proteins 0.000 description 2
- 241000259840 Chaetomidium Species 0.000 description 2
- 108090000746 Chymosin Proteins 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 101000613820 Homo sapiens Osteopontin Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000673329 Kluyveromyces hubeiensis Species 0.000 description 2
- 241000500414 Kluyveromyces wickerhamii Species 0.000 description 2
- 241000481961 Lachancea thermotolerans Species 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 2
- 201000010859 Milk allergy Diseases 0.000 description 2
- 241000233654 Oomycetes Species 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000233639 Pythium Species 0.000 description 2
- 241000223252 Rhodotorula Species 0.000 description 2
- 241000218589 Streptomyces olivaceus Species 0.000 description 2
- 241000223892 Tetrahymena Species 0.000 description 2
- 241000223230 Trichosporon Species 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 241000589636 Xanthomonas campestris Species 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 150000001450 anions Chemical group 0.000 description 2
- 229940054340 bacillus coagulans Drugs 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000013622 capto Q Substances 0.000 description 2
- 238000005277 cation exchange chromatography Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940080701 chymosin Drugs 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000007863 gel particle Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012807 shake-flask culturing Methods 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000009105 vegetative growth Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 241000620196 Arthrospira maxima Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 241000193833 Bacillales Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 108050008461 Beta-lactoglobulin Proteins 0.000 description 1
- 101000910039 Bos taurus Alpha-S1-casein Proteins 0.000 description 1
- 101000741059 Bos taurus Alpha-S2-casein Proteins 0.000 description 1
- 101000741065 Bos taurus Beta-casein Proteins 0.000 description 1
- 101000761239 Bos taurus Kappa-casein Proteins 0.000 description 1
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 description 1
- 101000613814 Bos taurus Osteopontin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000626645 Canariomyces Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 101000946378 Canis lupus familiaris Alpha-lactalbumin Proteins 0.000 description 1
- 241000123346 Chrysosporium Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241000609458 Corynespora Species 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 241000178951 Endomyces Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000170036 Endosporium Species 0.000 description 1
- 101000934136 Equus caballus Beta-casein Proteins 0.000 description 1
- 101000793856 Equus caballus Kappa-casein Proteins 0.000 description 1
- 241001465321 Eremothecium Species 0.000 description 1
- 241001334574 Erythromyces Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241001583499 Glomeromycotina Species 0.000 description 1
- 241000589232 Gluconobacter oxydans Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000741048 Homo sapiens Alpha-S1-casein Proteins 0.000 description 1
- 101000946384 Homo sapiens Alpha-lactalbumin Proteins 0.000 description 1
- 101000947120 Homo sapiens Beta-casein Proteins 0.000 description 1
- 101000793859 Homo sapiens Kappa-casein Proteins 0.000 description 1
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 1
- 101000703512 Homo sapiens Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 1
- 241001468155 Lactobacillaceae Species 0.000 description 1
- 241001112724 Lactobacillales Species 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 241001468194 Leuconostoc mesenteroides subsp. dextranicum Species 0.000 description 1
- 102000019298 Lipocalin Human genes 0.000 description 1
- 108050006654 Lipocalin Proteins 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 241000183011 Melanocarpus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 241000226677 Myceliophthora Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000192494 Oscillatoriales Species 0.000 description 1
- 102100040557 Osteopontin Human genes 0.000 description 1
- 101000741069 Ovis aries Alpha-S1-casein Proteins 0.000 description 1
- 101000741064 Ovis aries Alpha-S2-casein Proteins 0.000 description 1
- 101000946371 Ovis aries Alpha-lactalbumin Proteins 0.000 description 1
- 101000947110 Ovis aries Beta-casein Proteins 0.000 description 1
- 101000898348 Ovis aries Kappa-casein Proteins 0.000 description 1
- 101001121461 Ovis aries Osteopontin Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241001524101 Rhodococcus opacus Species 0.000 description 1
- 241000119319 Rhodococcus opacus PD630 Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000235343 Saccharomycetales Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000228389 Sporidiobolus Species 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 241001149962 Sporothrix Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 241000936794 Streptomyces chattanoogensis Species 0.000 description 1
- 241000187392 Streptomyces griseus Species 0.000 description 1
- 241000970906 Streptomyces natalensis Species 0.000 description 1
- 241000187134 Streptomyces olivochromogenes Species 0.000 description 1
- 241000187417 Streptomyces rubiginosus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000248392 Tetrahymena hegewischi Species 0.000 description 1
- 241000223891 Tetrahymena hyperangularis Species 0.000 description 1
- 241000248419 Tetrahymena malaccensis Species 0.000 description 1
- 241000248418 Tetrahymena pyriformis Species 0.000 description 1
- 241000248384 Tetrahymena thermophila Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241001000247 Xanthophyllomyces Species 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 241000758405 Zoopagomycotina Species 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 238000003453 ammonium sulfate precipitation method Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940011019 arthrospira platensis Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940072440 bovine lactoferrin Drugs 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000020246 buffalo milk Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000020248 camel milk Nutrition 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 235000020252 horse milk Nutrition 0.000 description 1
- 102000050459 human LTF Human genes 0.000 description 1
- 102000051312 human SPP1 Human genes 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000021244 human milk protein Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 235000020255 yak milk Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Definitions
- This application belongs to the field of dairy product processing, and specifically relates to a milk protein composition and its preparation method and application.
- Milk is a universal source of nutrients, rich in protein, fat, lactose, minerals, vitamins and growth factors such as immunoglobulins and lactoferrin.
- Whey protein is divided into ⁇ -lactalbumin and ⁇ -lactoglobulin; casein mainly exists in the form of micelles, consisting of ⁇ S1 - Casein, ⁇ S2-casein, ⁇ -casein and ⁇ -casein (4:1:4:1).
- Casein contains almost all essential amino acids and is the most nutritionally valuable protein for newborn babies.
- casein can increase the absorption of calcium and phosphorus by newborn babies.
- Casein can release a variety of bioactive peptides after the action of proteases in the gastrointestinal tract of newborn babies. These active peptides regulate digestion, nutrition and immunity of pups. Kappa-casein can also stimulate the growth of beneficial bacteria in the gastrointestinal tract of newborn pups.
- ⁇ -Lactoglobulin is a high-quality protein in milk with a good amino acid ratio and high branched-chain amino acids. It also has the unique ability of the lipocalin family to bind hydrophobic ligands, such as fat-soluble nutrients.
- the combination of beta-carotene, retinol, unsaturated fatty acids and vitamin E can serve as a carrier or solvent for these fat-soluble nutrients, thereby reducing the intake of fat.
- Whey protein is more soluble and contains higher quality essential amino acids.
- Whey protein has a high content of sulfur-containing amino acids, which is an important component of the biosynthesis of glutathione.
- Glutathione is a tripeptide related to antioxidant, anti-cancer and improving the body's immunity.
- Whey protein is also the highest natural source of branched-chain amino acids, which are thought to stimulate muscle protein synthesis.
- cow's milk is also one of the eight major allergens announced by the Food and Agriculture Organization of the United Nations. Its main allergens include casein, bovine serum albumin, ⁇ -lactoglobulin and ⁇ -lactalbumin, etc., affecting approximately 2%-6% of infants and young children.
- Milk allergy affects 0.1%-0.5% of adults. 82% of patients with milk allergy are allergic to ⁇ -lactoglobulin ( ⁇ -Lg). This is mainly because breast milk does not contain ⁇ -Lg, so ⁇ -Lg is the first protein that infants and young children encounter. It is a foreign protein that is not easily hydrolyzed by chymotrypsin and pepsin.
- ⁇ -Lg is considered to be the most important allergen in milk. Lactoglobulin is found in the whey of most mammals, but not in the whey of rodents, rabbits, and humans, which is one of the reasons why lactoglobulin is the main allergen in cow's milk.
- the purpose of this application is to provide a milk protein composition and its preparation method and application.
- the milk protein composition has an amino acid composition similar to that of natural milk protein and has at least lower allergenicity.
- a first aspect of the present application provides a milk protein composition, which contains lactoglobulin peptides, which are produced by degradation of recombinantly expressed ⁇ -lactoglobulin when expressed in host cells.
- the second aspect of this application provides a method for preparing the milk protein composition described in the first aspect of this application, which includes expressing the recombinantly expressed ⁇ -lactoglobulin in a host cell and recovering it from the host cell.
- the milk protein composition includes expressing the recombinantly expressed ⁇ -lactoglobulin in a host cell and recovering it from the host cell.
- the third aspect of the present application provides a food composition or feed composition, which contains the milk protein composition described in the first aspect of the present application.
- the milk protein composition provided by this application contains lactoglobulin peptides produced by the degradation of ⁇ -lactoglobulin.
- the fragments are smaller, and the solubility and in vitro digestibility are significantly better than that of natural ⁇ -lactoglobulin, thus having Nutritional value similar to or better than natural milk protein.
- the milk protein composition of the present application is obtained through heterologous expression, which can eliminate environmental pollution and animal welfare problems caused by natural milk production.
- the exogenously expressed milk protein composition contains less unhealthy components such as lactose, saturated fat, and cholesterol, and can be added to food instead of natural milk protein to improve the properties of the food and enrich the composition of the food. Improves the flavor of the product.
- Figure 1 is the fermentation broth supernatant of the Kluyveromyces marxianus expression strain at different times in Example 1 SDS-PAGE result chart;
- Figure 2A is a physical diagram of the milk protein composition obtained in Example 2.
- Figure 2B is an SDS-PAGE result diagram of the milk protein composition produced by the Kluyveromyces marxianus expression strain in Example 2;
- Figure 3 is an SDS-PAGE result diagram of the milk protein composition in the fermentation broth supernatant of the Kluyveromyces marxianus expression strain at different times in Example 3;
- Figure 4 is an SDS-PAGE result diagram of the milk protein composition in the fermentation broth supernatant of the Kluyveromyces marxianus expression strain at different times in Example 4;
- Figure 5 is a diagram of SDS-PAGE results of milk protein compositions prepared from different Kluyveromyces marxianus expression strains in Example 5;
- Figure 6 is an SDS-PAGE result diagram of the milk protein composition obtained by fermentation of Kluyveromyces lactis in Example 6;
- Figure 7 is a SDS-PAGE result diagram of the milk protein composition obtained in the comparative example.
- Figure 8 is a high performance liquid chromatogram of ⁇ -lactoglobulin standard
- Figure 9 is a high performance liquid chromatogram of the fermentation sample obtained in Example 2.
- the terms "about” and “similar to” mean within an acceptable error range for a particular value as determined by one of ordinary skill in the art, which error range may depend in part on how the value is measured or determined, or Depends on the limitations of the measurement system.
- milk protein refers to a protein found in milk produced by a mammal or having a sequence that is at least 50% (e.g., at least 50%, at least 55%, at least 60%, Proteins with at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99%, 100%) identical sequences.
- Non-limiting examples of milk proteins include beta-lactoglobulin, alpha-lactalbumin, kappa-casein, beta-casein, lactoferrin, alphaS1-casein, alphaS2-casein, and osteopontin, in addition to milk proteins. Proteins are known in the art.
- Protein refers to the polymerized form of amino acids, that is, two or more amino acids connected by peptide bonds. multimer.
- “Milk protein peptides” in this application particularly refers to a combination of peptides with different molecular weights produced by the degradation of one or more milk proteins.
- the milk protein peptides can be produced by the degradation of one milk protein or by multiple milk proteins. Produced by the degradation of milk proteins.
- nucleic acid e.g., a gene
- the term may be used, for example, to describe a nucleic acid that has been isolated from its naturally occurring environment, a nucleic acid that is no longer related in whole or in part to naturally adjacent or proximal nucleic acids, a nucleic acid that is not linked to a naturally occurring nucleic acid.
- Nucleic acid is an operably linked nucleic acid, or a nucleic acid that does not occur naturally.
- “recombinant” is used to describe a protein, it may refer, for example, to a protein that is produced in a different species or type of cell than the species or type of cell in which the protein is produced in nature.
- “Host cell” refers to a specific recipient cell and the progeny of such cells. Because certain modifications may occur in subsequent generations due to mutations or environmental influences, such progeny may actually differ from the parent cell but still be included within the scope of the term "host cell” as used herein. In this application, the "host cell” particularly refers to a cell used for heterologous expression of the recombinant milk protein.
- degradation has its general meaning, which refers to the process in which proteins are degraded into polypeptides and amino acids through the action of protein degrading enzymes. In this application, it especially refers to milk proteins expressed in host cells, which are unique in host cells. Under the action of protein degrading enzymes, it is degraded into a mixture of polypeptides with different molecular weights (ie, the milk protein peptides of the present application).
- Filamentous fungi refers to filamentous forms of organisms from the phyla Eumycota and Oomycota. Filamentous fungi differ from yeast by their hyphal elongation during vegetative growth.
- yeast refers to an organism of the order Saccharomycetales. Vegetative growth of yeast is by budding/bubbing of single-cell thalli, and carbon catabolism may be fermentative.
- Bacteria culture refers to the proliferation of bacterial cells under appropriate conditions.
- suitable conditions include suitable culture media (e.g., having suitable nutrient content [e.g., suitable carbon content, suitable nitrogen content, suitable phosphorus content], suitable supplement content, suitable trace metal content, appropriate pH value of the culture medium), appropriate temperature, appropriate feed rate, appropriate pressure, appropriate oxygenation level, appropriate culture duration, appropriate culture volume (i.e., culture containing recombinant host cells base volume) and suitable culture vessels.
- “Expression” refers to the process by which cells convert genetic information stored in DNA sequences into biologically active protein molecules through transcription and translation.
- vector means a nucleic acid molecule capable of transporting another nucleic acid to which it is linked.
- plasmid generally refers to a circular double-stranded DNA loop into which additional DNA segments (foreign genes) can be ligated, and may also include linear double-stranded molecules, such as those obtained from Amplification by polymerase chain reaction (PCR) or treatment of circular plasmids with restriction enzymes yields linear double-stranded molecules.
- PCR polymerase chain reaction
- viral vector in which additional DNA segments can be ligated into the viral genome.
- Certain vectors are capable of autonomous replication in the host cells into which they are introduced (e.g., have complexes that function in the host cell). vector for making starting points). Other vectors can be introduced into a host cell, integrated into the host cell's genome, and thus replicated with the host genome. In addition, certain preferred vectors are capable of directing the expression of foreign genes to which they are linked. In this application, the vector to which the foreign gene is connected is called a "recombinant expression vector" (or simply "expression vector”).
- a first aspect of the present application provides a milk protein composition, which contains lactoglobulin peptides, which are produced by degradation of recombinantly expressed ⁇ -lactoglobulin when expressed in host cells.
- the inventor unexpectedly found in the study that when recombinantly expressed ⁇ -lactoglobulin is expressed in host cells, degradation will occur, thereby producing corresponding lactoglobulin peptides.
- the milk protein composition containing lactoglobulin peptides of the present application less allergenic than natural milk protein.
- the milk protein composition further comprises recombinantly expressed ⁇ -lactoglobulin.
- the milk protein composition is directly expressed in the host cell.
- the milk protein composition is obtained by isolating and purifying the lactoglobulin peptide in a host cell.
- the milk protein composition contains more than 5% by weight, more than 10% by weight, more than 20% by weight, more than 30% by weight, more than 40% by weight, more than 50% by weight, more than 60% by weight , 70% by weight or more, 80% by weight or more, 90% by weight or more or 95% by weight or more of the lactoglobulin peptide.
- the milk protein composition contains less than 90% by weight, less than 80% by weight, less than 70% by weight, less than 60% by weight, less than 50% by weight, less than 40% by weight, and less than 30% by weight. below, 20% by weight below, 10% by weight below or below 5% by weight of the milk protein peptide.
- the content of the recombinantly expressed ⁇ -lactoglobulin is 0-95%; the content of the lactoglobulin peptide is 5%-100% ; Preferably, the content of the recombinantly expressed ⁇ -lactoglobulin is 10%-90%; the content of the lactoglobulin peptide is 10%-90%; Preferably, the recombinantly expressed ⁇ -lactoglobulin The content of the lactoglobulin peptide is 20%-80%; preferably, the content of the recombinantly expressed ⁇ -lactoglobulin is 30%-70%; the lactoglobulin peptide The content of the recombinantly expressed ⁇ -lactoglobulin is 30%-70%; preferably, the content of the recombinantly expressed ⁇ -lactoglobulin is 40%-60%; the content of the lactoglobulin peptide is 40%-60%.
- the milk protein composition also includes other recombinantly expressed milk proteins, and the other recombinantly expressed milk proteins may be recombinantly expressed ⁇ -lactalbumin, recombinantly expressed ⁇ -casein, recombinantly expressed ⁇ - at least one of casein, recombinantly expressed lactoferrin, recombinantly expressed ⁇ S1-casein, recombinantly expressed ⁇ S2-casein and recombinantly expressed osteopontin.
- the other recombinantly expressed milk proteins may be recombinantly expressed ⁇ -lactalbumin, recombinantly expressed ⁇ -casein, recombinantly expressed ⁇ - at least one of casein, recombinantly expressed lactoferrin, recombinantly expressed ⁇ S1-casein, recombinantly expressed ⁇ S2-casein and recombinantly expressed osteopontin.
- it can be: recombinant expression of ⁇ -lactoglobulin and recombinant expression of ⁇ -lactalbumin, recombinant expression of ⁇ -lactoglobulin and recombinant expression of ⁇ -casein, recombinant expression of ⁇ -lactoglobulin Protein and recombinant expression of ⁇ -casein, recombinant expression of ⁇ -lactoglobulin and recombinant expression of lactoferrin, recombinant expression of ⁇ -lactoglobulin and recombinant expression of ⁇ S1-casein, recombinant expression of ⁇ -lactoglobulin and recombinant expression of ⁇ S2-
- a combination of casein, recombinantly expressed ⁇ -lactoglobulin and recombinantly expressed osteopontin, or the combination of the above two recombinantly expressed milk proteins also includes other recombinantly expressed milk proteins, for example, it can be a
- Lactoglobulin combination of recombinant expression of lactoferrin and recombinant expression of ⁇ -lactalbumin, recombinant expression of ⁇ -lactoglobulin, combination of recombinant expression of lactoferrin and recombinant expression of ⁇ -casein, recombinant expression of ⁇ -lactoglobulin, The combination of recombinant expression of lactoferrin and recombinant expression of ⁇ -casein, the combination of recombinant expression of ⁇ -lactoglobulin, the combination of recombinant expression of lactoferrin and the recombinant expression of ⁇ S1-casein, etc.
- the other recombinant expression milk proteins can be directly expressed in the host cells to obtain the milk protein composition; they can also be added to the milk protein composition through exogenous addition. among things.
- the milk protein composition may further comprise other milk protein peptides produced by degradation of the other recombinantly expressed milk proteins when expressed in the host cell.
- the other milk protein peptides can be obtained by degradation when expressing the other recombinantly expressed milk proteins in the host cells, or can be added to the milk protein combination through exogenous addition. among things.
- the ⁇ -lactoglobulin can be cow, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee, Mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig, Wolf, fox, lion, tiger, echidna or mammoth beta-lactoglobulin.
- ⁇ -Lactoglobulin is a major allergen in milk produced by mammals (such as cow’s milk). The inventor found that the milk protein composition of the present application contains lactoglobulin peptides produced by the degradation of ⁇ -lactoglobulin, which can significantly reduce Sensitization by beta-lactoglobulin.
- the kappa-casein can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee , mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig , wolf, fox, lion, tiger, echidna or mammoth kappa-casein.
- the recombinant kappa-casein and the kappa-casein peptide produced by degradation when expressed in the host cell are beneficial to increase the solubility of the milk protein composition, making it easier to be absorbed by the organism.
- the alpha-lactalbumin can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee , mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig , wolf, fox, lion tiger, echidna or mammoth alpha-lactalbumin.
- the lactalbumin peptides produced by degradation of ⁇ -lactalbumin when expressed in the host cells are beneficial to further reducing the allergenicity of the milk protein composition.
- the ⁇ -casein can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee , mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig , wolf, fox, lion, tiger, echidna or mammoth beta-casein.
- the recombinant ⁇ -casein and the ⁇ -casein peptide produced by degradation when expressed in the host cell are beneficial to increase the solubility of the milk protein composition, making it easier to be absorbed by the organism.
- the lactoferrin can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee, Mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig, Wolf, fox, lion, tiger, echidna or mammoth lactoferrin.
- Recombinant lactoferrin and/or the lactoferrin peptide produced by degradation when expressed in the host cell has the effects of promoting the body's absorption of iron, inhibiting bacteria, improving intestinal flora, etc., making it Suitable for use as antibacterial and antiviral agents in food products such as infant formulas, functional dairy products and dietary supplements.
- the ⁇ S1-casein can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee , mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig , wolf, fox, lion, tiger, echidna or mammoth ⁇ S1-casein.
- the recombinant ⁇ S1-casein and the ⁇ S1-casein peptide produced by degradation when expressed in the host cell are beneficial to increase the solubility of the milk protein composition, making it easier to be absorbed by the organism.
- the ⁇ S2-casein can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee , mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig , wolf, fox, lion, tiger, echidna or mammoth ⁇ S2-casein.
- the recombinant ⁇ S2-casein and the ⁇ S2-casein peptide produced by degradation when expressed in the host cell are beneficial to increase the solubility of the milk protein composition, making it easier to be absorbed by the organism.
- the osteopontin can be bovine, human, sheep, goat, buffalo, camel, horse, donkey, lemur, panda, guinea pig, squirrel, bear, macaque, gorilla, chimpanzee, Mountain goat, monkey, ape, cat, dog, wallaby, rat, mouse, elephant, Opossum, rabbit, whale, baboon, gibbon, orangutan, mandrill, pig, wolf, fox, lion, tiger, echidna or mammoth osteopontin.
- osteopontin (OPN active protein) activity can directly reach the intestines, enhance the intestinal protective barrier function, achieve systemic immune protection, and reduce biological functions such as fever and discomfort by 50%.
- the content of osteopontin in the umbilical cord blood plasma of newborns and the plasma of 3-month-old infants is very high, about 7-10 times that of adults, suggesting that it is closely related to the growth and development of infants and young children in early life.
- At least one of the recombinantly expressed milk proteins comprises a protein related to cow milk protein, sheep milk protein, horse milk protein, goat milk protein, human milk protein, buffalo milk protein, camel milk protein, yak milk protein, etc.
- the amino acid sequence of the milk protein, dog milk protein, elephant milk protein, whale milk protein, bear milk protein, lion milk protein or tiger milk protein is at least 80%, at least 90% or at least 95% identical.
- the recombinantly expressed ⁇ -lactoglobulin comprises a combination with bovine ⁇ -lactoglobulin, buffalo ⁇ -lactoglobulin, yak ⁇ -lactoglobulin, sheep ⁇ -lactoglobulin, goat ⁇ -lactoglobulin, -Lactoglobulin, camel ⁇ -lactoglobulin, horse ⁇ -lactoglobulin, dog ⁇ -lactoglobulin, elephant ⁇ -lactoglobulin, whale ⁇ -lactoglobulin, bear ⁇ -lactoglobulin, lion ⁇ -
- the amino acid sequence of lactoglobulin or tiger beta-lactoglobulin has an amino acid sequence that is at least 80%, at least 90% or at least 95% identical.
- the recombinantly expressed lactoferrin comprises a combination with bovine lactoferrin, human lactoferrin, buffalo lactoferrin, yak lactoferrin, sheep lactoferrin, goat lactoferrin, camel lactoferrin protein, equine lactoferrin, dog lactoferrin, elephant lactoferrin, whale lactoferrin, bear lactoferrin, lion lactoferrin or tiger lactoferrin having an amino acid sequence of at least 80%, at least 90%, or at least 95 % identity of the amino acid sequence.
- the recombinantly expressed ⁇ -lactalbumin includes a combination with bovine ⁇ -lactalbumin, human ⁇ -lactalbumin, buffalo ⁇ -lactalbumin, yak ⁇ -lactalbumin, sheep ⁇ -lactalbumin, goat ⁇ -lactalbumin, ⁇ -lactalbumin, camel ⁇ -lactalbumin, horse ⁇ -lactalbumin, dog ⁇ -lactalbumin, elephant ⁇ -lactalbumin, whale ⁇ -lactalbumin, bear ⁇ -lactalbumin, lion ⁇ -lactalbumin or tiger ⁇ -lactalbumin
- the amino acid sequence of lactalbumin has an amino acid sequence that is at least 80%, at least 90% or at least 95% identical.
- the recombinantly expressed kappa-casein comprises a combination with bovine kappa-casein, human kappa-casein, buffalo kappa-casein, yak kappa-casein, sheep kappa-casein, goat ⁇ -casein, camel ⁇ -casein, horse ⁇ -casein, dog ⁇ -casein, elephant ⁇ -casein, whale ⁇ -casein, bear ⁇ -casein, lion ⁇ -casein or tiger ⁇ -casein
- the amino acid sequence of casein has an amino acid sequence that is at least 80%, at least 90%, or at least 95% identical.
- the recombinantly expressed ⁇ -casein comprises a combination with bovine ⁇ -casein, human ⁇ -casein, buffalo ⁇ -casein, yak ⁇ -casein, sheep ⁇ -casein, goat Beta-casein, camel beta-casein, horse beta-casein, dog beta-casein, elephant beta-casein, whale beta-casein, bear beta-casein, lion beta-casein or tiger beta-casein
- the amino acid sequence of casein has an amino acid sequence that is at least 80%, at least 90%, or at least 95% identical.
- the recombinantly expressed ⁇ S1-casein comprises a combination with bovine ⁇ S1-casein, human ⁇ S1-casein, buffalo ⁇ S1-casein, yak ⁇ S1-casein, sheep ⁇ S1-casein, goat ⁇ S1-casein, camel ⁇ S1-casein, horse ⁇ S1-casein, dog ⁇ S1-casein, elephant ⁇ S1-casein, whale ⁇ S1-casein, bear ⁇ S1-casein, lion ⁇ S1-casein or tiger ⁇ S1-casein
- the amino acid sequence of casein has an amino acid sequence that is at least 80%, at least 90%, or at least 95% identical.
- the recombinantly expressed ⁇ S2-casein comprises a combination with bovine ⁇ S2-casein, human ⁇ S2-casein, buffalo ⁇ S2-casein, yak ⁇ S2-casein, sheep ⁇ S2-casein, goat ⁇ S2-casein, camel ⁇ S2-casein, horse ⁇ S2-casein, dog ⁇ S2-casein, elephant ⁇ S2-casein, whale ⁇ S2-casein, bear ⁇ S2-casein, lion ⁇ S2-casein or tiger ⁇ S2-
- the amino acid sequence of casein has an amino acid sequence that is at least 80%, at least 90%, or at least 95% identical.
- the recombinantly expressed osteopontin comprises a combination with bovine osteopontin, human osteopontin, buffalo osteopontin, yak osteopontin, sheep osteopontin, goat osteopontin, camel osteopontin protein, horse osteopontin, dog osteopontin, elephant osteopontin, whale osteopontin, bear osteopontin, lion osteopontin or tiger osteopontin has an amino acid sequence of at least 80%, at least 90%, or at least 95 % identity of the amino acid sequence.
- the host cell is selected from fungal cells, bacterial cells, or protozoan cells.
- the fungal cells include, but are not limited to, Ascomycotas, Basidiomycota, Zygomycota, Chythridiomycota, Oomycota ) and organisms of the phylum Glomeromycota, exemplarily, the fungus is selected from yeast or filamentous fungi.
- the yeast includes, but is not limited to, Candida, Cladosporium, Cryptococcus, Debaromyces, Endosporium Endomyces, Endomycopsis, Eremothecium, Hansenula, Kluyveromyces, Lipomyces, Pichia (Pichia), Rhodosporidium, Rhodotorula, Saccharomyces, Sporobolomyces, Sporidiobolus, Trichosporon , at least one species of Xanthophyllomyces, Yarrowia, and Zygosaccharomyces.
- the Kluyveromyces genus includes, but is not limited to, Kluyveromyces marxianus, Kluyveromyces marxianus, Kluyveromyces lactis, At least one of Kluyveromyces hubeiensis, Kluyveromyces wickerhamii and Kluyveromyces thermotolerans.
- the filamentous fungal cells include, but are not limited to, Acremonium spp., Aspergillus spp., Ceratospora spp., Neosartoria spp., Aureobasidium spp., Canariomyces, Trichosporon spp.
- Chaetomidium Chaetomidium, Corynespora, Chrysosporium, Echinacea, Collarspora, Fusarium, Gibberellus, Humicola, Hypocrea, Lentinus, Oryzae oryzae Malbranchium, Melanocarpus, Mortierella, Mucor, Myceliophthora, Lactobacillus, Neocanthellae, Neurospora, Paecilomyces, Penicillium, Phenerochaete, Erythromyces Pythium, Ruminochytrid, Pythium, Rhizopus, Schizophyllum, Acremonium, Sporothrix, Pleurosporium, Talaromycetes, Thermoascomycota, Thermophilic Fungi , at least one species of the genus Thielavia, Trichoderma, and Trichoderma.
- bacteria include, but are not limited to, Firmicutes, Cyanobacteria (blue-green algae), Oscillatoriophcideae, Bacillales, Lactobacilli Members of the order Lactobacillales, Oscillatoriales, Bacillaceae, Lactobacillaceae, and any of the following genera, and their derivatives and hybrids: Acinetobacter, Acetobacter (Acetobacter) (e.g., Acetobacter suboxydans, Acetobacter xylinum), Actinoplane (e.g., Actinoplane missouriensis), Arthrospira Arthrospira (e.g., Arthrospiraplatensis, Arthrospira maxima), Bacillus (e.g., Bacillus cereus, Bacillus coagulans) coagulans), Bacillus licheniformis, Bacillus stearothermophilus, Bacillus subtilis), Escherichia (e.
- Acinetobacter Aceto
- Protozoa in this application refers to organisms of the phylum Protozoa, which are lower single-celled eukaryotes. For example, it may be Tetrahymena thermophila, Tetrahymena hegewischi, Tetrahymena hyperangularis, Tetrahymena malaccensis, Tetrahymena colourspot, Tetrahymena pyriformis or Tetrahymena bulimia.
- the fungal cell is selected from at least one of Kluyveromyces, Pichia, Aspergillus, and Fusarium; the bacterial cell is selected from Lactobacillus or Bacillus At least one species of the genus.
- the Bacillus genus includes Bacillus cereus, Bacillus coagulans, Bacillus licheniformis, Bacillus stearothermophilus, and At least one species of Bacillus subtilis.
- the Lactobacillus genus includes at least one of Lactobacillus acidophilus and Lactobacillus bulgaricus.
- the host cell is selected from at least one of Kluyveromyces marxianus or Kluyveromyces lactis.
- the inventor found that expressing recombinant ⁇ -lactoglobulin in Kluyveromyces marxianus or Kluyveromyces lactis can obtain more degradation products—lactoglobulin peptides.
- the inventors also found that there are more active peptides in the lactoglobulin peptides obtained using the host cells.
- the active peptides mentioned in this application refer to peptide fragments with biological functions, such as peptide fragments with ACE inhibitory activity.
- the milk protein composition further includes host cell proteins.
- the milk protein composition contains more than 5% by weight, more than 10% by weight, more than 20% by weight, more than 30% by weight, more than 40% by weight, more than 50% by weight, more than 60% by weight , 70% by weight or more, 80% by weight or more or 90% by weight or more of the host cell protein.
- the milk protein composition contains less than 90% by weight, less than 80% by weight, less than 70% by weight, less than 60% by weight, less than 50% by weight, less than 40% by weight, and less than 30% by weight. below, 20 wt% below, 10 wt% below, 5 wt% below, or 1 wt% below the host cell protein.
- the protein content of the host cells is 1-40%, preferably 1-20%, based on the total mass of the milk protein composition.
- the host cell protein is at least one of the extracellular secreted proteins of Kluyveromyces marxianus or Kluyveromyces lactis.
- the extracellular secreted protein is biosafe, edible, and can be used as a nutritional component supplemented into the milk protein composition.
- the milk protein composition includes 1-40% host cell protein, 5-90% lactoglobulin peptide and 5-90% recombinant ⁇ -lactoglobulin.
- the milk protein composition contains 1-20% host cell protein, 40-60% lactoglobulin peptide and 20-55% recombinantly expressed ⁇ -lactoglobulin.
- the second aspect of this application provides a method for preparing the milk protein composition described in the first aspect of this application, which includes expressing the recombinantly expressed ⁇ -lactoglobulin in a host cell and recovering it from the host cell.
- the milk protein composition includes expressing the recombinantly expressed ⁇ -lactoglobulin in a host cell and recovering it from the host cell.
- the preparation method of the milk protein composition described in the first aspect of the application provided in this application may include:
- the expression vector capable of expressing the ⁇ -lactoglobulin is introduced into the host cell using known methods, such as lipofection, electrotransfection, transformation, etc.; in a cell suitable for the expression of the ⁇ -lactoglobulin Culturing the host cell under conditions to allow the host cell to express the ⁇ -lactoglobulin; using methods known in the art, such as size exclusion chromatography, ultrafiltration through a membrane or density centrifugation based on its molecular weight, Isolate proteins or peptides. Proteins or peptides can also be separated based on their surface charge by isoelectric precipitation, anion/cation exchange chromatography.
- Proteins or peptides can also be separated by ammonium sulfate precipitation based on their solubility. Hydrophobic interaction chromatography can also be used to separate proteins or peptides by their affinity to another molecule. Affinity chromatography can also exploit the binding properties of the stationary phase to separate proteins or peptides. The expressed ⁇ -lactoglobulin and/or the lactoglobulin peptides produced by its degradation are recovered from the host cells, thereby obtaining the milk protein composition of the present application.
- the recovery of the milk protein composition from the host cell further includes a separation and purification step.
- the separation and purification can be a method known in the art, such as size exclusion chromatography, membrane filtration. method, isoelectric point precipitation method, anion/cation exchange chromatography, ammonium sulfate precipitation method, affinity chromatography, etc., this application is not limited here.
- the separation and purification step can obtain lactoglobulin peptide with higher purity.
- the host cell is selected from fungal cells, bacterial cells, or protozoan cells.
- the fungal cell is selected from at least one member of the genus Kluyveromyces, Pichia, Aspergillus, and Fusarium.
- the Kluyveromyces species comprise Max. Kluyveromyces marxianus, Kluyveromyces marxianus var., Kluyveromyces lactis, Kluyveromyces hubeiensis, Kluyveromyces wickerhamii and resistant At least one species of Kluyveromyces thermotolerans.
- the milk protein composition can be expressed in Kluyveromyces marxianus or Kluyveromyces lactis.
- the inventor unexpectedly found that using the host cell Expressing the ⁇ -lactoglobulin can obtain a higher yield of lactoglobulin peptides, which contain more functional peptides.
- the host cell protein is biosafe, edible, and can Supplemented into the milk protein composition as a nutritional component.
- the time for expressing the one or more recombinantly expressed milk proteins in the host cell is 12-168 hours, preferably 36-84 hours.
- the temperature at which the one or more recombinant expression milk proteins are expressed in the host cell is 20-45°C, preferably 25-40°C.
- the third aspect of the present application provides a food composition or feed composition, which contains the milk protein composition described in the first aspect of the present application.
- Strains used in this application include:
- Kluyveromyces marxianus (K.marxianus) CJA0001, deposited in the China Type Culture Collection Center, the deposit number is CCTCC No: M20211601, the deposit date is December 13, 2021, and the deposit address is Wuhan University, Wuhan, China , the classification is named Kluyveromyces marxianus CJA0001.
- Kluyveromyces marxianus (K.marxianus) CJA0002, deposited in the China Type Culture Collection Center, the deposit number is CCTCC No: M20211602, the deposit date is December 13, 2021, and the deposit address is Wuhan University, Wuhan, China , the classification is named Kluyveromyces marxianus CJA0002.
- Kluyveromyces marxianus K.marxianus CJA0003, deposited in the China Type Culture Collection Center, the deposit number is CCTCC No: M20211603, the deposit date is December 13, 2021, and the deposit address is Wuhan University, Wuhan, China , classified as Kluyveromyces marxianus CJA0003.
- Kluyveromyces marxianus was purchased from the China Industrial Microbial Culture Collection Center (CICC), numbered CICC 1953, and purchased in September 2020.
- CICC China Industrial Microbial Culture Collection Center
- Rubybacter lactis was purchased from the China Industrial Microbial Culture Collection Center (CICC), with the number CICC 32428, and the purchase time was May 2021.
- CICC China Industrial Microbial Culture Collection Center
- the milk protein composition and its preparation method of the present application will be described below through specific examples.
- the bovine ⁇ -lactoglobulin gene fragment (NCBI Gene ID: 113901792) was synthesized at GenScript Biotechnology Co., Ltd. and named ⁇ -Lg.
- ⁇ -Lg as a template, obtain the target gene through PCR amplification (upstream primer F1: 5'-GGCTGAAGCTTTGATCGTTACCCAAACTATG-3'SEQ ID No: 1, downstream primer R1: 5'-GGAGATCTTAAATGTGACATTGTTCTTCC-3'SEQ ID No: 2);
- the commercial vector pKLAC1 was amplified by PCR primers (upstream primer F2: 5'-CAATGTCACATTTAAGATCTCCTAGGGGTACC-3'SEQ ID No: 3, R2: 5'-GTAACGATCAAAGCTTCAGCCTCTTTTCTC-3'SEQ ID No: 4).
- the target gene is connected to the commercial pKLAC1 vector through seamless assembly to obtain the expression vector pKLAC1- ⁇ -Lg.
- ⁇ -lactoglobulin continues to be generated and degraded, until about 60 hours , the ratio of ⁇ -lactoglobulin and ⁇ -lactoglobulin peptide is roughly stable at 2:3. There was no exogenous protein or degradation product production in the control strain, and the protein staining results are not shown.
- Extraction of milk protein composition Use membrane filtration method to purify the fermentation broth supernatant. Filtration conditions, first 2-stage filter element: precision filter element + NF nanofiltration membrane; NF nanofiltration membrane specification: NF-4040; filtration precision: 0.001 ⁇ m; molecular cutoff value: ⁇ 200D; water inlet pressure: 0.2-0.3Mpa; working pressure :0.5-0.7Mpa.
- concentration process the nanofiltration membrane is backwashed every 10 minutes. After the concentration is completed, the concentrated liquid is recovered, weighed and recorded to obtain the milk protein composition of the present application, which is stored in a 4°C cold storage for later use.
- Example 2 Expanding fermentation system to prepare milk protein composition
- the 50L fermentation process is as follows:
- Example 1 Shake flask seed culture, take 1.5 mL of the K.marxianus::pKLAC1- ⁇ -Lg bacterial liquid cultured for 24 hours in Example 1 and inoculate it into 100 mL of liquid seed culture medium (peptone 20g/L, yeast powder 10g/L , glucose 10g/L, galactose 10g/L) in a 250mL Erlenmeyer flask, culture at 30°C, 220rpm for 12h to obtain the seed liquid.
- liquid seed culture medium peptone 20g/L, yeast powder 10g/L , glucose 10g/L, galactose 10g/L
- Secondary seed culture prepare 200mL seed liquid and connect it to the secondary seed culture medium (5L tank), 30°C, 220rpm, culture for 6-8h, OD reaches about 10-12, and obtain the secondary seed liquid.
- Fermentation culture add the secondary seed liquid into 50L of batch fermentation medium (20g/L peptone, 10g/L yeast powder, 10g/L glucose, 10g/L galactose) according to the inoculum amount of 10%.
- Batch culture is carried out in the fermentation tank with an initial liquid volume of 22-25L.
- Example 3 Expanding fermentation system to prepare milk protein composition
- the 1T fermentation process is as follows:
- First-level shake flask seed culture 2 mL of K.marxianus::pKLAC1- ⁇ -Lg glycerol bacteria from Example 1 was added to 200 mL of LYPD medium (500 mL shake flask), 30°C, 220 rpm, cultured for 16 hours, and the OD reached about 12. Obtain first-level seed liquid.
- Secondary seed shake flask culture 7mL of primary seed liquid is connected to 700mL of secondary shake flask culture medium (20g/L peptone, 10g/L yeast powder, 10g/L glucose, 10g/L galactose), 30°C. 220rpm, culture for 16h, OD reaches about 12, and obtain the secondary seed liquid.
- 40L/150L seed tank (g) 40L/150L seed tank (g)
- peptone 20g/L peptone 20g/L
- yeast powder 10g/L glucose 10g/L
- galactose 10g /L galactose 10g /L
- air volume 40L/min dissolved oxygen and rotation speed
- Example 3 Except that the fermentation culture time in step 4 was extended to 108 hours, the rest was the same as in Example 3.
- the SDS-PAGE results are shown in Figure 4. From the figure, ⁇ - Lactoglobulin and milk Production of globin peptides.
- linearized pKLAC1- ⁇ -Lg was transformed into Kluyveromyces marxianus of different origins: strain 1 K. marxianus CJA0002 (CCTCC No: M20211602), strain 2 K. marxianus CJA0003 (CCTCC No: M20211603), strain 2 3K. marxianus (CICC 1953), obtain an expression strain, and use the same conditions as in Example 1 for fermentation, detection, and purification of the fermentation product to obtain a milk protein composition.
- linearized pKLAC1- ⁇ -Lg was transformed into Kluyveromyces lactis (Kluyveromyces lactis, deposit number CICC 32428), K.lactis::pKLAC1- ⁇ -Lg was constructed, and the control strain K.lactis was constructed at the same time: :pKLAC1.
- Cultivate Kluyveromyces lactis in a fermentation medium (peptone 20g/L, yeast powder 10g/L, glucose 10g/L, galactose 10g/L); adjust the pH of the medium to 5.5-6.5, after 25-30
- the fermentation was carried out for 72 hours at °C, and galactose was added during the fermentation process to induce protein expression, and the fermentation broth was obtained.
- the fermentation broth was purified and detected by SDS-PAGE using the same method as in Example 1.
- SDS-PAGE results of the milk protein compositions of the control strain and the transformed strain are shown in Figure 6. It can be seen that lactoglobulin peptides can also be obtained by using Kluyveromyces lactis to exogenously express ⁇ -lactoglobulin.
- Example 1 Using the ⁇ -Lg of Example 1 as a template, PCR amplified the lactoglobulin fragment (F1: 5'-AAAGAGAGGCTGAAGCTT ACTTGATCGTTACCCAAACTAT-3'SEQ ID No: 5, R1: 5'-AGGCGAATTAATTCGCGGCCTCAAATGTGACATTGTTCTT-3'SEQ ID No: 6) , the PCR product was ligated with the pPIC9k plasmid digested by SnaBI/NotI-HF to construct the Pichia pastoris expression plasmid pPIC9k- ⁇ -Lg.
- the pPIC9k- ⁇ -Lg plasmid linearized by SalI enzyme was transformed into Pichia pastoris GS115 to construct P.pastoris::pPIC9k- ⁇ -Lg.
- the control strain P.pastoris::pPIC9k was constructed.
- the strains obtained above were successively used by BMGY
- the culture medium (Brand: Solarbio; Product No.: LA5250) and BMMY culture medium (Brand: Solarbio; Product No.: LA5250) are used for fermentation, and different volumes of methanol are added every day to keep the final content of methanol in the fermentation broth at 1%, and the fermentation is continued for 5 sky.
- the supernatant was collected by centrifugation, concentrated by centrifugation, and quantitatively analyzed using SDS-PAGE.
- the fermentation broth was purified and detected by SDS-PAGE using the same method as in Example 1. The results are shown in Figure 7. Lane 1 in the figure is the control strain, and lanes 2-9 are the constructed expression strains. It was found that using Pichia pastoris Lactoglobulin peptide cannot be obtained through fermentation. In order to verify this conclusion, this example was repeated many times, and the experimental results were consistent.
- the HPLC-MS protein gel sequencing method was used to identify the components of the milk protein peptides in the milk protein compositions of Examples 1, 5, and 6.
- the fermentation broth supernatant was subjected to SDS-PAGE analysis, and gel strips of different molecular weight sizes were pretreated.
- the gel pieces were immersed in a buffer of 50 mmNH 4 HCO 3 and 50% (v/v) acetonitrile (ACN) until Decolorize; incubate with 100% ACN for 5 minutes and then remove ACN to complete the first dehydration, and add 10mM dithiothreitol (DTT) and incubate at 5°C for 60 minutes for the first hydration; the hydrated gel
- the strip was dehydrated again using 100% ACN for the second time, and incubated with 55mM iodoacetamide (IAA) at room temperature for 45 minutes in the dark to perform the second hydration; the hydrated strip was again dehydrated using 50mm NH 4 HCO 3 and 100 %ACN performs the third dehydration.
- ACN acetonitrile
- LC-MS/MS Re-dissolve the dried peptide sample with mobile phase A (2% ACN, 0.1% FA (formic acid)), centrifuge at 20,000g for 10 minutes, and take the supernatant for injection. Separation was performed by Thermo UltiMate 3000UHPLC.
- the sample is first enriched and desalted in the trapping column, and then enters the self-packing C18 column (internal diameter 75 ⁇ m, column size 3 ⁇ m, column length 25 cm), and is separated at a flow rate of 300 nL/min through the following effective gradient: 0 to 5 min, 5% Mobile phase B (98% ACN, 0.1% FA); 5 to 45 minutes, mobile phase B increases linearly from 5% to 25%; 45 to 50 minutes, mobile phase B increases from 25% to 35%; 50 to 52 minutes, mobile phase B increased from 35% to 80%; 52-54min, 80% mobile phase B; 54-60min, 5% mobile phase B.
- the nanoliquid phase separation end is directly connected to the mass spectrometer.
- Peptides separated by liquid chromatography were ionized by a nanoESI source and then detected by a tandem mass spectrometer Q-Exactive HF X (Thermo Fisher Scientific, San Jose, CA) in DDA (data-dependent acquisition) mode.
- Main parameter settings ion source voltage is set to 1.9kV, MS1 scanning range is 350 ⁇ 1,500m/z; resolution is set to 60,000; MS2 starting m/z is fixed at 100; resolution is 15,000.
- MS2 fragmentation ion screening conditions the first 30 precursor ions with a charge of 2 + to 6 + and a peak intensity exceeding 10,000.
- the ion fragmentation mode was HCD, and fragment ions were detected in Orbitrap.
- Dynamic exclusion time is set to 30 seconds.
- AGC settings are: MS13E6, MS21E5.
- Table 2 List of lactoglobulin peptides identified by mass spectrometry 2
- Table 1 shows that in the ⁇ -lactoglobulin gel segment, the amino acid sequences of the polypeptides with high ion scores among the detected polypeptides are shown in SEQ ID No: 7 to 10, among which SEQ ID No: 7 has been queried the most times.
- Table 2 shows that in the lactoglobulin peptide gel segment, the amino acid sequences of the polypeptides with high ion scores among the detected polypeptides are shown in SEQ ID Nos: 7, 10 and 11 respectively, and SEQ ID Nos: 7 to 11 are all It comes from ⁇ -lactoglobulin, not bacterial protein, or other metabolite proteins.
- composition ratio of each polypeptide fragment contained in the lactoglobulin peptide decomposed during the expression process is compared with the complete form that existed before decomposition. There are significant differences in expression, making the two show unexpected differences in various activity assays.
- Example 1 the components of milk protein peptides in the milk protein compositions of Example 1 and Example 5 were compared respectively.
- the results showed that different Kluyveromyces marxianus expressed exogenous ⁇ -lactoglobulin and were able to hydrolyze it to produce milk protein peptides.
- the lactoglobulin peptide composition is close, indicating that different host cells of the present application can produce the lactoglobulin peptide of the present application.
- the milk protein compositions in the examples of the present application also contain a certain amount of host cell proteins.
- the applicant conducted activity analysis on the milk protein composition unexpectedly, the applicant found that the milk protein composition of the present application has ACE inhibitory activity. It can be judged from this that the milk protein composition of the present application has higher nutritional value.
- the antigenicity of ⁇ -LG in the 12-hour, 36-hour, and 72-hour fermentation broth samples of Example 1 was evaluated using an ELISA detection kit (product number: ml036565, manufacturer: Shanghai Enzyme Biotechnology Co., Ltd.).
- a1 Take 10 mL of fermentation broth supernatant, centrifuge at 12000 rpm/min for 5 min, take the supernatant, adjust the pH to 7.5/8.5 with NaOH, and filter with a 0.45 ⁇ m sterile needle filter.
- AKTAPure 150 protein purification system was tested on the machine. Use ultrapure water to flush the entire flow path for 5 column volumes at a flow rate of 5mL/min; balance 5 column volumes with buffer A at a flow rate of 5mL/min; before loading the sample. Buffer A cleans the loop, and the sample loading flow rate is 3mL/min; use buffers containing 100mM, 200mM, 300mM, 400mM, and 500mM NaCl to perform staged elution, with a flow rate of 5mL/min.
- Nanofiltration Take the permeate of K.marxianus::pKLAC1 and K.marxianus::pKLAC1- ⁇ -Lg collected in b1 above and perform nanofiltration purification. Inject an appropriate amount of pure water into the concentrated water tank, start the nanofiltration machine, and use clean water to flush the nanofiltration machine forward and back until the water is clear and has no peculiar smell. After pre-rinsing the nanofiltration machine, add b1 permeate. Start the nanofiltration machine and booster pump. After normal liquid discharge, adjust the opening of the concentrated water return valve to control the concentrated water return pressure at 0.04-0.08Mpar. During the concentration process, the nanofiltration membrane is backwashed every 10 minutes. Nanofiltration membrane precision: 0.001 ⁇ m; molecular cutoff value: ⁇ 200DA. After the concentration is completed, recover and weigh the concentrated liquid to record the quality, and store it in a 4°C cold storage for later use.
- Nanofiltration Take the K.marxianus::pKLAC1 and K.marxianus::pKLAC1- ⁇ -Lg permeate collected in c1 above and perform nanofiltration purification. Inject an appropriate amount of pure water into the concentrated water tank, start the nanofiltration machine, and use clean water to flush the nanofiltration machine forward and back until the water is clear and has no peculiar smell. After pre-rinsing the nanofiltration machine, add b1 permeate. Start the nanofiltration machine and booster pump. After normal liquid discharge, adjust the opening of the concentrated water return valve to control the concentrated water return pressure at 0.04-0.08Mpar. During the concentration process, the nanofiltration membrane is backwashed every 10 minutes. Nanofiltration membrane precision: 0.001 ⁇ m; molecular cutoff value: ⁇ 200DA. After the concentration is completed, recover and weigh the concentrated solution, record the quality, and store it in a 4°C cold storage spare.
- c3 The sum of the concentrations of K.marxianus::pKLAC1- ⁇ -Lg ultrafiltration and nanofiltration concentrates minus the sum of the concentrations of K.marxianus::pKLAC1 ultrafiltration and nanofiltration concentrates is used as K.marxianus expression ⁇ -lactosphere Proteolytically produced beta-lactoglobulin and beta-lactoglobulin compositions.
- Nanofiltration conditions First 2-stage filter element: precision filter element + NF nanofiltration membrane; NF nanofiltration membrane specification: NF-4040; filtration precision: 0.001 ⁇ m; molecular cutoff value: ⁇ 200D; water inlet pressure: 0.2-0.3Mpa; working Pressure: 0.5-0.7Mpa.
- concentration process the nanofiltration membrane is backwashed every 10 minutes. After the concentration is completed, the concentrated solution is recovered, weighed and recorded, and stored in a 4°C cold storage for later use.
- the milk protein composition prepared on d1 includes ⁇ -lactoglobulin, ⁇ -lactoglobulin peptide and K. marxianus extracellular secreted protein.
- Example 1 Milk protein composition fermented for 36 hours (G, comprising 50% by weight of recombinant ⁇ -lactoglobulin, 45% by weight of ⁇ -lactoglobulin peptide and 5% by weight of Kluyveromyces marxianus Extracellular secreted protein), the milk protein composition (H) fermented for 12 hours in Example 1, including 85% by weight of recombinant ⁇ -lactoglobulin, 10% by weight of ⁇ -lactoglobulin peptid
- the analysis method is: take the fermentation sample obtained in the above Example 2, prepare it to a concentration of 1g/L, and use commercial ⁇ -lactoglobulin (E) as a standard. Then Kjeldahl nitrogen determination, HPLC (high performance liquid chromatography) and Elisa (enzyme-linked immunosorbent) were used to detect the protein content in the two groups of samples. Based on the different principles of different detection methods, comparing the protein concentrations detected by different methods can Compare the allergenicity of each group of samples. The specific method is as follows:
- a1 Use Elisa kit (product number: ml036565, manufacturer: Shanghai Enzyme Biotechnology Co., Ltd.), in which the wells of the microtiter plate are pre-coated with bovine ⁇ -LG-specific antibodies. Different samples obtained using the above 4 methods were added to the wells and combined with specific antibodies and horseradish peroxidase (HRP)-conjugated specific antibodies.
- HRP horseradish peroxidase
- a2 The antibody-antigen-HRP-conjugated antibody complex and 3,3',5,5'-tetramethylenebenzidine (TMB) substrate solution will turn blue after adding the stop solution, and then turn to yellow .
- Optical density (OD) was measured spectrophotometrically at a wavelength of 450 nm. The OD value is proportional to antigenicity.
- Chromatographic conditions are: phase A pure water (containing 0.1% trifluoroacetic acid), phase C acetonitrile (containing 0.1% trifluoroacetic acid), column temperature 50°C, flow rate 1mL/min, sample loading 20 ⁇ L, detection wavelength 214nm, collection time 9min .
- the mobile phase gradient is as follows:
- Kjeldahl nitrogen detection is: decompose the protein, then combine the ammonia generated by the decomposition with sulfuric acid to form ammonium sulfate, then alkaline distillation to free the ammonia, absorb it with boric acid, and then titrate it with a sulfuric acid or hydrochloric acid standard solution. According to the acid consumption The amount multiplied by the conversion factor is the protein content.
- the protein content in the 1g/L sample to be tested prepared by Kjeldahl determination was 0.97g/L and 0.98g/L respectively.
- ⁇ -lactoglobulin was detected by HPLC.
- the fermentation sample composition The detection result was 0.89g/L, indicating that the sample was partially hydrolyzed.
- the Elisa detection result was 0.84g/L, indicating that the allergenicity of the fermented sample composition was reduced after hydrolysis.
- Protein solubility protein content in supernatant/protein content per 1g of sample. The test results are as follows:
- the detection steps are as follows:
- step d Determination of protein digestibility in vitro: Take 10 mL of the digested sample in step b or step c, add an equal volume of 24% trichloroacetic acid solution to precipitate the protein, centrifuge at 12000 r/min for 20 min, collect the supernatant, and use CaCl The nitrogen content was determined by the Nitrogen determination method, and then the digestibility was calculated using formula (1), in which distilled water was used to replace the milk sample digestive fluid in the blank test.
- the chromatographic column is C18 (4.6mm ⁇ 250mm), the mobile phase A is water containing 0.1% (v/v) trifluoroacetic acid, and the mobile phase B is acetonitrile containing 0.1% (v/v) trifluoroacetic acid.
- Use gradient elution method is 30% to 60% B, 0 to 10 minutes; 60% to 30% B, 10 to 12 minutes; 30% B, hold for 2 minutes.
- the detector is an ultraviolet (UV) detector, the detection wavelength is 228nm, the sample volume is 20 ⁇ L, the flow rate is 1mL/min, the column temperature is 30°C, and each sample is measured three times in parallel.
- UV ultraviolet
- hippuric acid standard (HPLC, >98%) and prepare hippuric acid standard solutions with concentrations of 10 ⁇ g/mL, 20 ⁇ g/mL, 40 ⁇ g/mL, 60 ⁇ g/mL, 80 ⁇ g/mL, and 100 ⁇ g/mL (using 0.1 mol/ L of boric acid buffer), and filtered with a 0.45 ⁇ m micromembrane for HPLC analysis to determine that the standard concentration and detection peak area satisfy a linear relationship.
- the IC 50 result showed that the IC 50 of the fermentation sample obtained in Example 2 was 11.34 ⁇ g/mL, which was higher than the 8.85 ⁇ g/mL of the purchased ⁇ -lactoglobulin standard.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Peptides Or Proteins (AREA)
- Dairy Products (AREA)
Abstract
L'invention concerne une composition de protéine de lait, son procédé de préparation et son utilisation, la composition de protéine de lait comprenant un peptide de lactoglobuline, et le peptide de lactoglobuline étant obtenu par dégradation de la β-lactoglobuline recombinante lorsqu'il est exprimé dans une cellule hôte. L'invention concerne également une composition alimentaire ou une composition alimentaire comprenant la composition de protéine de lait mentionnée ci-dessus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210540990 | 2022-05-17 | ||
CN202210540990.2 | 2022-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023221994A1 true WO2023221994A1 (fr) | 2023-11-23 |
Family
ID=88834673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/094598 WO2023221994A1 (fr) | 2022-05-17 | 2023-05-16 | Composition de protéine de lait, son procédé de préparation et son utilisation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023221994A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105237627A (zh) * | 2015-10-21 | 2016-01-13 | 中国科学院新疆理化技术研究所 | 一种低分子量牛乳铁蛋白肽抗菌肽的纯化方法 |
CN107474131A (zh) * | 2017-09-26 | 2017-12-15 | 广州中国科学院先进技术研究所 | 一种重组牛血清蛋白成熟肽及其制备方法和应用 |
CN107501406A (zh) * | 2017-09-26 | 2017-12-22 | 广州中国科学院先进技术研究所 | 一种重组牛β‑乳球蛋白及其制备方法和应用 |
CN107853697A (zh) * | 2011-12-07 | 2018-03-30 | N.V.努特里奇亚 | 用于治疗牛乳蛋白过敏症的β‑乳球蛋白肽 |
CN107964040A (zh) * | 2017-11-13 | 2018-04-27 | 江苏大学 | 乳球蛋白活性肽的超声辅助模拟消化方法及功能食品应用 |
-
2023
- 2023-05-16 WO PCT/CN2023/094598 patent/WO2023221994A1/fr unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107853697A (zh) * | 2011-12-07 | 2018-03-30 | N.V.努特里奇亚 | 用于治疗牛乳蛋白过敏症的β‑乳球蛋白肽 |
CN105237627A (zh) * | 2015-10-21 | 2016-01-13 | 中国科学院新疆理化技术研究所 | 一种低分子量牛乳铁蛋白肽抗菌肽的纯化方法 |
CN107474131A (zh) * | 2017-09-26 | 2017-12-15 | 广州中国科学院先进技术研究所 | 一种重组牛血清蛋白成熟肽及其制备方法和应用 |
CN107501406A (zh) * | 2017-09-26 | 2017-12-22 | 广州中国科学院先进技术研究所 | 一种重组牛β‑乳球蛋白及其制备方法和应用 |
CN107964040A (zh) * | 2017-11-13 | 2018-04-27 | 江苏大学 | 乳球蛋白活性肽的超声辅助模拟消化方法及功能食品应用 |
Non-Patent Citations (1)
Title |
---|
ZHANG YUTAO: "Biological activity of β-lactoglobulin in milk and its influencing factors", CHINA DAIRY CATTLE., no. 2, 1 February 2010 (2010-02-01), pages 43 - 45, XP093108960 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yadav et al. | Cheese whey: A potential resource to transform into bioprotein, functional/nutritional proteins and bioactive peptides | |
Mollea et al. | Valorisation of cheese whey, a by-product from the dairy industry | |
Korhonen et al. | Bioactive peptides: Production and functionality | |
Korhonen et al. | Food-derived bioactive peptides-opportunities for designing future foods | |
Bayram et al. | Antioxidant activity of whey protein fractions isolated by gel exclusion chromatography and protease treatment | |
CN103254278B (zh) | 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法 | |
Tavares et al. | Whey proteins as source of bioactive peptides against hypertension | |
Korhonen et al. | Bioactive peptides from food proteins | |
Cao et al. | Purification and identification of an ACE inhibitory peptide from the peptic hydrolysate of Acetes chinensis and its antihypertensive effects in spontaneously hypertensive rats | |
Castro-Martínez et al. | Overexpression of a modified protein from amaranth seed in Escherichia coli and effect of environmental conditions on the protein expression | |
EP2309874A1 (fr) | Procédé pour préparer un hydrolysat de protéines | |
Aluko | Structural characteristics of food protein‐derived bitter peptides | |
CN116789793A (zh) | 一种乳蛋白组合物及其制备方法和应用 | |
WO2023221994A1 (fr) | Composition de protéine de lait, son procédé de préparation et son utilisation | |
Morales-Camacho et al. | Insertions of antihypertensive peptides and their applications in pharmacy and functional foods | |
TW202413407A (zh) | 使用絲狀真菌之免疫球蛋白或多聚體免疫球蛋白之製造方法 | |
JP2003250460A (ja) | 乳蛋白質の機能性改質方法 | |
Li et al. | Safety evaluation, hydrolysis activity of Kluyveromyces marxianus JY-1 and its application to obtain immunomodulatory peptide from bovine casein | |
Dimou et al. | Valorization of cheese whey to “bio”-value added food products with industrial interest and their potential beneficial health effects | |
Dullius et al. | Bioactive peptide production in fermented foods | |
Salvado et al. | Enzymatic production of bioactive peptides from whey proteins: Their active role and potential health benefits | |
Chen et al. | Production of Angiotensin-I-Converting Enzyme inhibitory peptide from goat milk casein: optimization conditions of complex protease hydrolysate by response surface methodology and purification | |
Huang et al. | The growth-promoting effects of protein hydrolysates and their derived peptides on probiotics: structure-activity relationships, mechanisms and future perspectives | |
Wang et al. | Peptidomics approaches to the discovery and ACE inhibitory effect of casein peptides derived from fermented bovine milk by kefir grains | |
Emkani et al. | Pea Protein Extraction Assisted by Lactic Fermentation: Impact on Protein Profile and Thermal Properties. Foods 2021, 10, 549 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23806945 Country of ref document: EP Kind code of ref document: A1 |